Roche to rein­tro­duce oc­u­lar im­plant two years af­ter pulling it off the mar­ket

Roche plans to rein­tro­duce Susvi­mo, its oc­u­lar im­plant pulled al­most two years ago for man­u­fac­tur­ing is­sues, in the com­ing weeks.

In late 2022, the com­pa­ny’ …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.